IP Library Granted Patent US 7,744,853
Granted Patent B2
US 7,744,853 · App. 11/236,272 · Granted Jun 29, 2010

Radiolabeled annexins

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,744,853
App. No.
11/236,272
Granted
Jun 29, 2010
Kind
B2
Abstract

Radiolabeled annexin and modified annexin conjugates useful for imaging vascular thrombi are described. Methods for making and using such radiolabeled annexin conjugates are also provided.

Claims (9)

1. A modified annexin which is direct radiolabeled with a metal radionuclide, comprising a metal radionuclide complexed directly to a modified annexin, wherein the annexin is modified by the addition of a sulfhydryl group comprised of an N-terminal extension of the annexin, the N-terminal extension comprising a cysteine residue within ten amino acids of the N-terminus of the modified annexin.

2. The modified annexin of claim 1 , wherein the modification of the annexin comprises an amino acid extension at the N-terminus, said amino acid extension comprising a sequence X-Cys-X-X-X-X wherein X signifies an amino acid residue.

3. The modified annexin of claim 2 , wherein the N-terminal extension comprises a sequence Ala-Cys-Asp-His-Ser-Met.

4. The modified annexin of claim 2 , wherein the amino acid extension further comprises glycine.

5. The modified annexin of claim 2 , wherein the annexin is annexin V.

6. The modified annexin of any one of claims 1 - 4 and 5 , wherein the radionuclide is a diagnostic radionuclide.

7. The modified annexin of any one of claims 1 - 4 and 5 , wherein the radionuclide is Cu-64, Cu-67, Re-186, Re-188, Pd-100, Pd-109, Bi-212, Pb-212, Ga-67, Ga-68, Tc-99 m, Tc-94, Ru-95, Ru-105, Rh-99, Rh-105, In-111, Sm-153, Lu-177, Lu-170, Pt-189, Pt-193, Au-199 or Hg-197.

8. The modified annexin of claim 7 , wherein the radionuclide is Cu-64, Cu-67, Re-186, Re-188, Pd-100, Pd-109, Bi-212, Pb-212, Ga-67, Ga-68, Tc-99 m, Tc-94, Ru-95, Ru-105, Rh-99, Rh-105 or In-111.

9. The modified annexin of claim 8 , wherein the radionuclide is Tc-99 m.